Search Results 81-90 of 17065 for monoclonal antibody

1. Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma - Mayo Clinic

   GA101 is an anti-CD20 humanized and glyco-engineered monoclonal antibody. GA101 has been shown to have increased antibody-dependent cellular cytotoxicity ...

2. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

   Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

3. Multiple myeloma - Symptoms and causes - Mayo Clinic

   The myeloma cells continue trying to make antibodies, as healthy plasma cells do. But the body can't use these antibodies, called monoclonal proteins or M ...

4. Mayo Clinic research finds immune system responds to mRNA treatment for cancer

   Dong and his team produced an immune system protein in the lab ― a monoclonal antibody ― that can detect the protein levels in tumor tissues. The goal was ...

5. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types - Mayo Clinic

   ... monoclonal antibody, and compare them with clinical outcomes. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...

6. Publications - Raymund R. Razonable, M.D. - Mayo Clinic

   ... monoclonal antibody therapy in solid organ transplant recipients. J Med Virol. 2023 Jun; 95 (6):e28885. View PubMed; Ordaya EE, Higgins EM, Vergidis P ...

7. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

   Brentuximab vedotin is a combining monoclonal antibody with an anticancer drug that binds to a protein on the surface of lymphoma cells called cluster of ...

8. Rituximab-abbs (intravenous route) - Mayo Clinic

   Rituximab-abbs is a monoclonal antibody. Rituximab-abbs injection is used together with other cancer medicines (eg, fludarabine and cyclophosphamide) to ...

9. Clinical trials - Oncology (Medical)

   Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...

10. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...